COVOVAX Clinical Trials Begins in India: ICMR Partners With Serum Institute of India For Conducting Phase 2/3 Bridging Clinical Trial Of COVID-19 Vaccine

ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)